![]() |
市場調査レポート
商品コード
1316301
スポーツ医学の世界市場-2023年~2030年Global Sports Medicine Market - 2023-2030 |
||||||
カスタマイズ可能
適宜更新あり
|
スポーツ医学の世界市場-2023年~2030年 |
出版日: 2023年07月27日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
|
世界のスポーツ医学市場は、2022年に70億米ドルに達し、2030年には113億米ドルに達し、有利な成長が予測されています。世界のスポーツ医学市場は、予測期間中(2023-2030年)に6.3%のCAGRを示すと予測されています。
スポーツ傷害の増加、製品発売の増加、新しい治療法の導入、再生医療の進歩、低侵襲手術に対する要求の高まりなどが、予測期間中に世界のスポーツ医学市場の成長を押し上げると予想される要因の一つです。
市場開発の増加は、予測期間における世界のスポーツ医学市場の成長を後押しすると予測されます。例えば、2023年3月、医療技術企業であるSmith+Nephewは、新しいQUADTRAC大腿四頭筋腱採取ガイドシステム、X-WING移植片準備システム、ULTRABUTTON調整可能固定装置ファミリーで構成されるUltraTRAC QUAD ACL再建術を発売しました。
同様に、2022年7月、コロラドスプリングスで開催される2022年 American Orthopaedic Society for Sports Medicine(AOSSM)年次総会において、世界の医療技術企業であるSmith+Nephewは、洗練された関節修復ソリューションのいくつかと幅広い教育活動のコレクションを特徴とする強力なラインナップを発表しました。
増加する進歩は、世界のスポーツ医学市場に有利な成長機会をもたらしています。例えば、2023年6月、 Aspetar, Orthopaedic, and Sports Medicine Hospitalは衝撃波療法を導入し、スポーツ医学の最前線に立っています。
この最先端技術を採用したこの最先端の治療法は、スポーツに関連した怪我の組織回復と痛みの減少に変化をもたらし、アスリートや個人に影響力のあるインパクトを与えています。
スポーツ医学のために新たに開発された医薬品の承認のための厳格な規制機関の存在は、予測期間における世界市場の成長を妨げています。例えば、スポーツ医学の認可および商業化を監督する主な規制機関には、米国食品医薬品局(USFDA)および欧州医薬品庁(EUの医薬品評価および監督を担当するEUの機関)が含まれます。
COVID-19のパンデミックと世界各国でのロックダウンにより、あらゆる業種の企業の財務の健全性が影響を受けています。そのため、COVID-19公衆衛生緊急事態の期間中、米国食品医薬品局(FDA)は、スポンサーと研究者を支援し、試験参加者の安全を確保し、適正臨床実施基準(GCP)を遵守し、試験の完全性に対するリスクを最小限に抑えるための一般的な考慮事項を含むガイドラインを発表しました。
ロシア・ウクライナ紛争は、スポーツ傷害の発生率が低く、この地域には主要な市場プレーヤーがいないため、世界のスポーツ医学市場に中程度の影響を及ぼすと考えられます。ウクライナの診療所は、ロシア軍からの侵攻を受け入れ続けているもの、死者数の増加や限られた医療援助に追われています。あらゆる医薬品が不足しています。また、基本的な材料の輸出入の重要性は、予測期間における世界のスポーツ医学市場の成長に若干の影響を与えると予想されます。
The global sports medicine market reached US$ 7.0 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 11.3 billion by 2030. The global sports medicine market is expected to exhibit a CAGR of 6.3% during the forecast period (2023-2030).
The increase in the number of sports injuries, rising product launches, introductions of new therapies, advancements in regenerative medicine, and increasing requirements for minimally invasive surgery are among the factors expected to boost the global sports medicine market growth in the forecast period.
The increasing market developments are estimated to boost the global sports medicine market growth in the forecast period. For instnace, in March 2023, Smith+Nephew, medical technology corporation, launched the UltraTRAC QUAD ACL Reconstruction Technique comprising of the new QUADTRAC Quadriceps Tendon Harvest Guide System, X-WING Graft Preparation System and family of ULTRABUTTON Adjustable Fixation Devices.
Likewise, in July 2022, Smith+Nephew, the global medical technology corpoLikewisentroduced a potent line-up featuring a few of its refined joint repair solutions and a wide collection of educational actions in the 2022 American Orthopaedic Society for Sports Medicine (AOSSM) Annual Meeting being held in Colorado Springs.
The increasing advancements are presenting the global sports medicine market with lucrative growth opportunities. For instnace, in June 2023, Aspetar, Orthopaedic, and Sports Medicine Hospital introduced its Shockwave Therapy putting it at the forefront of sports medicine.
Employing this cutting-edge technology, this state-of-the-art therapy modality is altering tissue restoration and pain drop-in sports-associated injuries, making an influential impact on athletes and individuals.
The presence of stringent regulatory bodies for the approval of newly developed drugs for sports medicine is hampering the global market growth in the forecast period. For instnace, the major regulatory bodies supervising the authorization and commercialization of sports medicine include the United States Food and Drug Administration (USFDA) and the European Medicines Agency, an agency of the European Union in charge of the evaluation and supervision of pharmaceutical products in the European Union.
The financial health of companies across all industries has been impacted by the COVID-19 pandemic and lockdown in numerous nations throughout the world. Therefore, for the period of the COVID-19 public health emergency, the U.S. Food and Drug Administration (FDA) issued guidelines that include general considerations to aid sponsors and researchers, ensuring the safety of trial participants, adhering to good clinical practice (GCP), and minimizing risks to trial integrity.
The Russia-Ukraine conflict is thought to hold a moderate influence on the global sports medicine market, as there is a low incidence of sports injuries and a lack of primary market players in this region. Though continuing to countenance invasions from Russian armies, Ukrainian clinics are forced by growing numbers of deaths and limited medical aid. There are shortages across all Products of medications. Again, the significance of the import and export of fundamental materials are expected to slightly impact the global sports medicine market growth in the forecast period.
The global sports medicine market is segmented based on product, application, end-user, and region.
Owing to the increasing product introduction for the foot and ankle sports-injury applications segment into the global sports medicine market, the segment is estimated to hold a large share of the global market accounting for about 43.9%. For instance, in June 2022, Mueller Sports Medicine, an industry leader in sports medicine for the last six decades, launched its SKY Ankle Stabilizer.
As ankle sprains are the No.1 sports injury, SKY Stabilizer strives to deliver fit ankles and avert chronic ankle instability. It was developed for participants interested in vertical jumping sports such as basketball and volleyball as Mueller concentrated on simple elements of inversion sprains and biomechanics.
Owing to the increasing incidences of sports injury in this region the European sports medicine market is estimated to hold around 27.6% of the global market share by 2030. For instance, in September 2022, London - Howden, the international insurance vendor, reported its European Football Injury Index for the 2021/2022 season for the guys' tournament, which demonstrates that injury expenses for the mainland's leading leagues broke via the half-a-billion-pound spot for the very foremost term (£513.23m/€610.75m). The whole number of injuries sustained throughout Europe's top five clubs was around 4,810 over the course of the previous season denoting a 20% boost in the 2020/2021 season.
The major global players in the sports medicine market include: Arthrex Inc., CONMED Corporation, Johnson & Johnson, Medtronic PLC, Mueller Sports Medicine Inc., Performance Health, Smith & Nephew, Stryker Corporation, Wright Medical Group, Zimmer Biomet Holdings Inc. among others.
The global sports medicine market report would provide approximately 53 tables, 54 figures, and 195 Pages.
LIST NOT EXHAUSTIVE